Shanghai Jiao Tong University School of Medicine: Leukemia trials

The registry lists 10 Leukemia studies with Shanghai Jiao Tong University School of Medicine as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 2 7Phase 3 2Phase 4 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid LeukemiaRecruitingNCT06980155Early Phase 1
• Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic LeukemiaRecruitingNCT06607419Phase 2/3
• Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid MalignanciesRecruitingNCT05991908Phase 3
• Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi LeukemiaRecruitingNCT05870995Phase 2
• Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.Status unknownNCT04904237Phase 2
• Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid LeukemiaStatus unknownNCT04353479Phase 2
• Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALLStatus unknownNCT02766868Phase 2
• Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APLStatus unknownNCT01987297Phase 4
• Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute LeukemiaStatus unknownNCT01498016Phase 2
• ASCT for Relapsed APL After Molecular RemissionTerminatedNCT00907582Phase 2